Company News for Nov 30, 2021

Zacks Equity Research Published on November 30, 2021

Krystal Biotech, Inc.’s (KRYS - Free Report) shares jumped more than 100% after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational beremagene geperpavec for dystrophic Epidermolysis Bullosa.
Shares of Adagio Therapeutics, Inc. surged 86.4% after the company reported that its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models with all other variants of concern identified previously.
NRx Pharmaceuticals, Inc.’s (NRXP - Free Report) shares jumped 20% after the company announced positive data from its ZYESAMI study.
Shares of Hertz Global Holdings, Inc. (HTZ - Free Report) rose nearly 6% after the car rental company announced a new stock repurchase program of up to $2 billion.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.